It's no secret that cannabis companies are facing some formidable challenges when it comes to raising capital, thanks to marijuana's onerous classification as a Schedule I controlled substance under federal law. But now with potential changes on the horizon, such as cannabis rescheduling and banking reform, more companies just might improve their financial positions and attract new investments.

Even now, in anticipation of potential regulatory changes, there's been an increase in capital raises. Frank Colombo, managing director of data analytics and investment banking at Viridian Capital Advisors, provided an overview of capital raising trends the Benzinga Cannabis...